Therefore, we have identified a new function of FXR, which exerts pivotal effect in the immune microenvironment, not only by regulating the level of PD-L1 in HCC cells but also by affecting tumor-derived Exos to regulate CD4+ T cell immune costimulatory targets. The gene discussed is CD4; the disease is neoplasm.